AKUMS DRUGS & PHARMACEUTICALS
Back to Cashflow Statement
|
AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹73 Cr | ₹-108 Cr | ₹125 Cr | ₹236 Cr | ₹-95 Cr |
What is the latest Cash Flow from Financing Activities ratio of AKUMS DRUGS & PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹73 Cr |
| Mar2024 | ₹-108 Cr |
| Mar2023 | ₹125 Cr |
| Mar2022 | ₹236 Cr |
| Mar2021 | ₹-95 Cr |
How is Cash Flow from Financing Activities of AKUMS DRUGS & PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹73 Cr | Positive | |
| Mar2024 | ₹-108 Cr | Negative | |
| Mar2023 | ₹125 Cr | -47.24 | |
| Mar2022 | ₹236 Cr | Positive | |
| Mar2021 | ₹-95 Cr | - | |
Compare Cash Flow from Financing Activities of peers of AKUMS DRUGS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AKUMS DRUGS & PHARMACEUTICALS | ₹9,764.3 Cr | 14% | 15.2% | 8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,428.0 Cr | 1% | -0.9% | 6.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,426.0 Cr | 1.8% | -2.3% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,603.0 Cr | 3.7% | 6.5% | 44.9% | Stock Analytics | |
| CIPLA | ₹111,604.0 Cr | 0% | 4.7% | -8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,775.0 Cr | -0.2% | 0.7% | -3.4% | Stock Analytics | |
AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AKUMS DRUGS & PHARMACEUTICALS | 14% |
15.2% |
8% |
| SENSEX | 3.7% |
2.2% |
-7.2% |
You may also like the below Video Courses